(Q34755148)

4 August 2017

1 reference

title

Ofloxacin. A reappraisal of its use in the management of genitourinary tract infections (English)

1 reference

4 August 2017

S V Onrust

1

1 reference

4 August 2017

H M Lamb

series ordinal

2

1 reference

4 August 2017

J A Balfour

series ordinal

3

1 reference

4 August 2017

publication date

1 November 1998

1 reference

4 August 2017

1 reference

4 August 2017

volume

56

1 reference

4 August 2017

issue

5

1 reference

4 August 2017

page(s)

895-928

1 reference

https://scigraph.springernature.com/pub.10.2165/00003495-199856050-00015

4 August 2017

exact match

0 references

cites work

In vitro susceptibilities of isolates of Haemophilus ducreyi from Thailand and the United States to currently recommended and newer agents for treatment of chancroid

1 reference

12 December 2020

Urinary tract infections in elderly women.

1 reference

12 December 2020

Management of urinary tract infections in adults

1 reference

12 December 2020

Single-dose efficacy of ofloxacin in uncomplicated gonorrhea

1 reference

12 December 2020

Safety of ofloxacin--adverse drug reactions reported during phase-II studies in Europe and in Japan

1 reference

12 December 2020

Susceptibilities of Chlamydia trachomatis isolates causing uncomplicated female genital tract infections and pelvic inflammatory disease

1 reference

12 December 2020

Urinary pharmacodynamics of low-dose ciprofloxacin and ofloxacin

1 reference

12 December 2020

Ceftriaxone in the prevention of postoperative infection in patients undergoing transurethral resection of the prostate

1 reference

12 December 2020

Treatment of urinary tract infection. Clinical and economic considerations

1 reference

12 December 2020

Treatment of nongonococcal urethritis: comparison of ofloxacin and erythromycin

1 reference

12 December 2020

Fluoroquinolone (Lomefloxacin) International Surveillance Trial: A report of 30 months of monitoring in vitro activity

1 reference

12 December 2020

Cefuroxime axetil versus ofloxacin for short-term therapy of acute uncomplicated lower urinary tract infections in women.

1 reference

12 December 2020

Lack of effect of amoxycillin on the absorption of ofloxacin

1 reference

12 December 2020

Kinetics and comparative efficacy of ofloxacin versus co-trimoxazole in the asymptomatic bacteriuria of elderly subjects.

1 reference

12 December 2020

Effects of ofloxacin on the pharmacokinetics and pharmacodynamics of procainamide

1 reference

12 December 2020

3-day course of ofloxacin versus cefalexin in the treatment of urinary tract infections in postmenopausal women.

1 reference

12 December 2020

Effect of quinolones on the human intestinal microflora

1 reference

12 December 2020

Concentration of ofloxacin and ciprofloxacin in human semen following a single oral dose.

1 reference

12 December 2020

Correlation between in vitro antimicrobial susceptibilities and beta-lactamase plasmid contents of isolates of Haemophilus ducreyi from the United States

1 reference

12 December 2020

Fosfomycin trometamol versus ofloxacin/co-trimoxazole as single dose therapy of acute uncomplicated urinary tract infection in females: a multicentre study

1 reference

12 December 2020

The safety profile of ofloxacin.

1 reference

12 December 2020

A randomised controlled trial of ofloxacin 200 mg 4 times daily or twice daily vs ciprofloxacin 500 mg twice daily in elderly nursing home patients with complicated UTI

1 reference

12 December 2020

Pharmacokinetics and serum bactericidal titers of ciprofloxacin and ofloxacin following multiple oral doses in healthy volunteers

1 reference

12 December 2020

Serum bactericidal activity against Enterobacteriaceae producing broad-spectrum beta-lactamases in volunteers administered ofloxacin and cefotaxime, alone or combined.

1 reference

12 December 2020

Effects of two cations on gastrointestinal absorption of ofloxacin

1 reference

12 December 2020

Single-dose treatment of female acute uncomplicated cystitis

1 reference

12 December 2020

Absorption of oral ofloxacin after cytotoxic chemotherapy for haematological malignancy

1 reference

12 December 2020

[Ofloxacin concentration in human prostatic tissue after 3 days of administration]

1 reference

12 December 2020

Oral ofloxacin therapy of infections due to multiply-resistant bacteria

1 reference

12 December 2020

Penetration of ofloxacin into prostatic fluid, ejaculate and seminal fluid

1 reference

12 December 2020

Clinical evaluation of ofloxacin in the treatment of chronic complicated urinary tract infection

1 reference

12 December 2020

Optimal characteristics of agents to treat uncomplicated urinary tract infections

1 reference

12 December 2020

Comparative penetration of lomefloxacin and other quinolones into human phagocytes

1 reference

12 December 2020

In vitro and in vivo antibacterial activities of Q-35, a novel fluoroquinolone

1 reference

12 December 2020

Multicenter in vitro comparative study of fluoroquinolones against 25,129 gram-positive and gram-negative clinical isolates.

1 reference

12 December 2020

Comparative in-vitro and in-vivo activity of AM-1155 against anaerobic bacteria

1 reference

12 December 2020

Pharmacokinetics of ofloxacin and the effect on the faecal flora of healthy volunteers.

1 reference

12 December 2020

The serum concentrations of desmethyl ofloxacin and ofloxacin N-oxide in seriously ill patients and their possible contributions to the antibacterial activity of ofloxacin

1 reference

12 December 2020

Comparison of inhibitory effects of new quinolones on drug metabolizing activity in the liver

1 reference

12 December 2020

In vitro activities of 10 antimicrobial agents against bacterial vaginosis-associated anaerobic isolates from pregnant Japanese and Thai women.

1 reference

12 December 2020

Comparison of ofloxacin and ceftriaxone in the treatment of uncomplicated gonorrhea caused by penicillinase-producing and non-penicillinase-producing strains

1 reference

12 December 2020

Overview of postmarketing experience with ofloxacin in Germany

1 reference

12 December 2020

Spectrum and susceptibility of pathogens causing acute uncomplicated lower UTI in females and its correlation to bacteriologic outcome after single dose therapy with fosfomycin trometamol versus ofloxacin/Co-trimoxazole

1 reference

12 December 2020

Multicenter randomized trial of ofloxacin versus cefoxitin and doxycycline in outpatient treatment of pelvic inflammatory disease. Ambulatory PID Research Group.

1 reference

12 December 2020

Cefixime. A review of its therapeutic efficacy in lower respiratory tract infections.

1 reference

12 December 2020

Double-blind study comparing 3-day regimens of cefixime and ofloxacin in treatment of uncomplicated urinary tract infections in women

1 reference

12 December 2020

Susceptibility of Chlamydia trachomatis to trovafloxacin

1 reference

12 December 2020

Pharmacodynamic evaluation of ofloxacin and trimethoprim-sulfamethoxazole in vaginal fluid of women treated for acute cystitis

1 reference

12 December 2020

Single dose quinolone treatment in acute uncomplicated urinary tract infection in women

1 reference

12 December 2020

In-vitro and in-vivo activities of DW-116, a new fluoroquinolone

1 reference

12 December 2020

A randomized trial of ofloxacin versus cefoxitin and doxycycline in the outpatient treatment of acute salpingitis

1 reference

12 December 2020

Drug interactions with quinolones.

1 reference

12 December 2020

Microbial etiology of urban emergency department acute salpingitis: treatment with ofloxacin

1 reference

12 December 2020

Lack of effect of ketoprofen on the pharmacokinetics of pefloxacin and ofloxacin

1 reference

12 December 2020

Pathogenesis of pelvic inflammatory disease. What are the questions?

1 reference

12 December 2020

Occurrence of Ureaplasma urealyticus and Mycoplasma hominis in non-gonococcal urethritis before and after treatment in a double-blind trial of ofloxacin versus erythromycin

1 reference

12 December 2020

Ofloxacin versus doxycycline for treatment of cervical infection with Chlamydia trachomatis

1 reference

12 December 2020

Comparative effects of levofloxacin and ofloxacin on the normal oral and intestinal microflora

1 reference

12 December 2020

Sequential therapy with ofloxacin in complicated urinary tract infections: a randomized comparative study with ciprofloxacin

1 reference

12 December 2020

The use of fluoroquinolones in neutropenic patients--analysis of adverse effects

1 reference

12 December 2020

Ten-year survey of quinolone resistance in Escherichia coli causing urinary tract infections.

1 reference

12 December 2020

Quinolones as an alternative treatment of chlamydial, mycoplasma and gonococcal urogenital infections

1 reference

12 December 2020

Accumulation of a newly developed fluoroquinolone, OPC-17116, by human polymorphonuclear leukocytes

1 reference

12 December 2020

Optimal treatment of urinary tract infections in elderly patients

1 reference

12 December 2020

[Sequential parenteral and oral therapy with ofloxacin in urogenital infections]

1 reference

12 December 2020

The emergence of highly fluoroquinolone-resistant Escherichia coli in community-acquired urinary tract infections

1 reference

12 December 2020

Ofloxacin. A reappraisal of its antimicrobial activity, pharmacology and therapeutic use.

1 reference

12 December 2020

Persistence of Neisseria gonorrhoeae strains with decreased susceptibilities to ciprofloxacin and ofloxacin in Cleveland, Ohio, from 1992 through 1993

1 reference

12 December 2020

Tolerability of fluoroquinolone antibiotics. Past, present and future

1 reference

12 December 2020

In vitro and in vivo antibacterial activities of CFC-222, a novel broad spectrum fluoroquinolone.

1 reference

12 December 2020

Ofloxacin versus trimethoprim and co-trimoxazole in the treatment of uncomplicated urinary tract infection in general practice

1 reference

12 December 2020

Fluoroquinolone antimicrobial agents

1 reference

12 December 2020

Diagnostic and therapeutic problems in prostatitis. Therapeutic position of ofloxacin

1 reference

12 December 2020

Clinical efficacy of new quinolones for therapy of nongonococcal urethritis

1 reference

12 December 2020

Development of a rapid assay for detecting gyrA mutations in Escherichia coli and determination of incidence of gyrA mutations in clinical strains isolated from patients with complicated urinary tract infections.

1 reference

12 December 2020

In vitro and in vivo antibacterial activities of T-3761, a new quinolone derivative

1 reference

12 December 2020

Parenteral ofloxacin in treatment of pyelonephritis

1 reference

12 December 2020

Bacteria isolated in 1994-1995 in female upper genitalia infections and in male urethritis. Distribution and sensitivity to antibiotics

1 reference

12 December 2020

In vitro and in vivo antibacterial activities of CS-834, a new oral carbapenem.

1 reference

12 December 2020

Comparative pharmacokinetics of ofloxacin and ciprofloxacin

1 reference

12 December 2020

Bioequivalence of oral and intravenous ofloxacin after multiple-dose administration to healthy male volunteers

1 reference

12 December 2020

Multicenter open-label study of parenteral ofloxacin in treatment of pyelonephritis in adults

1 reference

12 December 2020

In-vitro and in-vivo antibacterial activity of CFC-222, a new fluoroquinolone.

1 reference

12 December 2020

Oral ofloxacin: a critical review of the new drug application

1 reference

12 December 2020

Ofloxacin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.

1 reference

12 December 2020

1998 guidelines for treatment of sexually transmitted diseases. Centers for Disease Control and Prevention

1 reference

12 December 2020

Oral absorption of ofloxacin administered together with aluminum

1 reference

12 December 2020

Effectiveness of ofloxacin in the treatment of Chlamydia trachomatis and Neisseria gonorrhoeae cervical infection

1 reference

12 December 2020

Ofloxacin in the treatment of gonococcal and chlamydial urethritis

1 reference

12 December 2020

Prostatic tissue levels of ofloxacin

1 reference

12 December 2020

Sequential antimicrobial therapy--the role of quinolones

1 reference

12 December 2020

Comparative study of the influence of Ca2+ on absorption parameters of ciprofloxacin and ofloxacin

1 reference

12 December 2020

Pharmacokinetics of gyrase inhibitors, Part 2: Renal and hepatic elimination pathways and drug interactions.

1 reference

12 December 2020

Ofloxacin pharmacokinetics in mechanically ventilated patients

1 reference

12 December 2020

Bactericidal activity of ciprofloxacin, norfloxacin and ofloxacin in serum and urine after oral administration to healthy volunteers.

1 reference

12 December 2020

Absence of interaction between ofloxacin and phenprocoumon

1 reference

12 December 2020

Randomized comparison of ofloxacin and doxycycline for chlamydia and ureaplasma urethritis and cervicitis

1 reference

12 December 2020

In vitro and in vivo antichlamydial activities of HSR-903, a new fluoroquinolone antibiotic

1 reference

12 December 2020

Clinical experience with ofloxacin in sexually transmitted disease

1 reference

12 December 2020

Influence of oral co-administered metallic drugs on ofloxacin pharmacokinetics

1 reference

12 December 2020

Oral ofloxacin versus intramuscular ceftriaxone in antibiotic prophylaxis in transurethral prostate resection

1 reference

12 December 2020

Effects of probenecid and cimetidine on renal disposition of ofloxacin in rats.

1 reference

12 December 2020

[Clinical evaluation of oral ofloxacin in 3-day therapy for transurethral resection of the prostate]

1 reference

12 December 2020

Multicenter randomized study of single-dose ofloxacin versus amoxicillin-probenecid for treatment of uncomplicated gonococcal infection

1 reference

12 December 2020

Comparison of 2 Oral Ofloxacin Regimens for the Treatment of Bacteriuria in Elderly Subjects

1 reference

12 December 2020

A multicentre study of the in-vitro activity of cefotaxime, cefuroxime, ceftazidime, ofloxacin and ciprofloxacin against blood and urinary pathogens.

1 reference

12 December 2020

Advances in the antimicrobial therapy of chlamydial genital infections

1 reference

12 December 2020

Efficacy of intravenous ofloxacin: a French multicentre trial in 185 patients

1 reference

12 December 2020

Fluorometric and high-performance liquid chromatographic measurement of quinolone uptake by human neutrophils

1 reference

12 December 2020

Comparative crossover assessment of serum bactericidal activity and pharmacokinetics of ciprofloxacin and ofloxacin.

1 reference

12 December 2020

Prevalence of important pathogens and antimicrobial activity of parenteral drugs at numerous medical centers in the United States, I. Study on the threat of emerging resistances: real or perceived? Fluoroquinolone Resistance Surveillance Group.

1 reference

12 December 2020

Evaluation of new anti-infective drugs for the treatment of urinary tract infection. Infectious Diseases Society of America and the Food and Drug Administration

1 reference

12 December 2020

Fluoroquinolones: interaction profile during enteral absorption.

1 reference

12 December 2020

Meta-analysis of quinolone-theophylline interactions

1 reference

12 December 2020

Single dose UTI prophylaxis in transurethral surgery. Oral ofloxacin vs parenteral cefotaxime

1 reference

12 December 2020

Ofloxacin, a new broad-spectrum fluoroquinolone. Results from a Multicenter, National Comparative Activity Surveillance Study. The Ofloxacin Surveillance Group

1 reference

12 December 2020

Ofloxacin in the management of complicated urinary tract infections, including prostatitis.

1 reference

12 December 2020

Comparison of i.v. ofloxacin and piperacillin in the treatment of complicated urinary tract infections

1 reference

12 December 2020

In vitro and in vivo antibacterial efficacies of CFC-222, a new fluoroquinolone.

1 reference

12 December 2020

Trends in bacterial resistance to fluoroquinolones

1 reference

12 December 2020

In vitro activity of enoxacin versus ciprofloxacin, fleroxacin, lomefloxacin, ofloxacin, pefloxacin, and rufloxacin against uropathogens

1 reference

12 December 2020

Severe infections treated with intravenous ofloxacin: a prospective clinical multicentre Swiss study

1 reference

12 December 2020

Ofloxacin in the treatment of urinary tract infection in renal transplant recipients

1 reference

12 December 2020

Side effects of ofloxacin in clinical trials and in postmarketing surveillance

1 reference

12 December 2020

[Ofloxacin concentration in prostatic tissue]

1 reference

12 December 2020

Correlation of serum ofloxacin concentration and serum creatinine level in patients on prolonged therapy.

1 reference

12 December 2020

Phase IV study and post-marketing surveillance of ofloxacin in Japan

1 reference

12 December 2020

Rufloxacin once daily versus ofloxacin twice daily for treatment of complicated cystitis and upper urinary tract infections. Italian Multicentre UTI Rufloxacin Group

1 reference

12 December 2020

High-level resistance to ciprofloxacin in Escherichia coli

1 reference

12 December 2020

[Comparative studies on activities of antimicrobial agents against causative organisms isolated from patients with urinary tract infections (1996), III. Secular changes in susceptibility].

1 reference

12 December 2020

Ofloxacin versus trimethoprim/sulfamethoxazole in the treatment of uncomplicated urinary tract infection

1 reference

12 December 2020

Single-dose and three-day regimens of ofloxacin versus trimethoprim-sulfamethoxazole for acute cystitis in women

1 reference

12 December 2020

Phase IV study (postmarketing surveillance) of Tarivid (ofloxacin) in China

1 reference

12 December 2020

In vitro activity and concentrations in serum, urine, prostatic secretion and adenoma tissue of ofloxacin in urological patients

1 reference

12 December 2020

Effect of enteral feeding with ensure on oral bioavailabilities of ofloxacin and ciprofloxacin

1 reference

12 December 2020

USA resistance patterns among UTI pathogens

1 reference

12 December 2020

Effect of sucralfate on absorption of norfloxacin and ofloxacin

1 reference

12 December 2020

Asymptomatic bacteriuria. Which patients should be treated?

1 reference

12 December 2020

Absence of pharmacokinetic interaction between ofloxacin and fenbufen in rats

1 reference

12 December 2020

Antichlamydial activities of newly developed fluoroquinolones and their potential future role in the treatment of chlamydial respiratory infections.

1 reference

12 December 2020

Application of ofloxacin in gynaecology.

1 reference

12 December 2020

10.2165/00003495-199856050-00015

Identifiers

DOI

1 reference

Dimensions Publication ID

4 August 2017

1020538299

0 references

1 reference